Overview Fundamentals API Earnings EOD API Sample Code Pricing

Y mAbs Therapeutics (YMAB NASDAQ) stock market data APIs

$14.04 0.22(1.6%) as of September 6, 2024
Price chart is built with Anychart

Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer in the United States and internationally. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment of pediatric patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow. The company is also developing DANYELZA for the treatment of patients with second-line relapsed osteosarcoma and is in Phase II clinical study; GD2-SADA, which is in Phase I clinical trial for the treatment of GD2 positive solid tumor; and Omburtamab, a murine monoclonal antibody for the treatment of central nervous system/leptomeningeal metastases from neuroblastoma, as well as SADA PRIT technology platform. In addition, it is engages in the developing of CD38-SADA and GD2-GD3 Vaccine. The company has a license agreement with Memorial Sloan Kettering Cancer Center and Massachusetts Institute of Technology to develop and commercialize licensed products. Y-mAbs Therapeutics, Inc. was incorporated in 2015 and is headquartered in New York, New York.

Y mAbs Therapeutics Financial Data Overview

13.82
14.04
-
14.42
13.27
4.69-20.9
616 M
44 570 K
86 546 K
-0.21
0.699
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'YMAB',
Type: 'Common Stock',
Name: 'Y mAbs Therapeutics',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00J2DBMZ8',
ISIN: NULL,
CUSIP: NULL,
CIK: '1722964',
EmployerIdNumber: '47-4619612',
FiscalYearEnd: 'December',
IPODate: '2018-09-21',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Y mAbs Therapeutics Fundamental Data is available in our Financial Data APIs

  • Net Revenue 86 546 K
  • EBITDA -27 004 000
  • Earnings Per Share -0.56
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Y mAbs Therapeutics Earnings via APIs

  • Latest Release 2024-08-12
  • EPS/Forecast -0.13

Get Y mAbs Therapeutics End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com